479 related articles for article (PubMed ID: 30682505)
21. Surgical outcome and molecular pattern characterization of recurrent glioblastoma multiforme: A single-center retrospective series.
Montemurro N; Fanelli GN; Scatena C; Ortenzi V; Pasqualetti F; Mazzanti CM; Morganti R; Paiar F; Naccarato AG; Perrini P
Clin Neurol Neurosurg; 2021 Aug; 207():106735. PubMed ID: 34119900
[TBL] [Abstract][Full Text] [Related]
22. Fluorescein-guided surgery for the resection of pilocytic astrocytomas: A multicentric retrospective study.
Falco J; Höhne J; Broggi M; Rubiu E; Restelli F; Vetrano IG; Schiariti M; Mazzapicchi E; Bonomo G; Ferroli P; Schebesch KM; Acerbi F
Front Oncol; 2022; 12():943085. PubMed ID: 36016608
[TBL] [Abstract][Full Text] [Related]
23. Molecular pathological expression in malignant gliomas resected by fluorescein sodium-guiding under the YELLOW 560 nm surgical microscope filter.
Zhang N; Shang Z; Wang Z; Meng X; Li Z; Tian H; Huang D; Yin X; Zheng B; Zhang X
World J Surg Oncol; 2018 Oct; 16(1):195. PubMed ID: 30285781
[TBL] [Abstract][Full Text] [Related]
24. Endoscope-assisted fluorescence-guided resection allowing supratotal removal in glioblastoma surgery.
Bettag C; Schregel K; Langer P; Thomas C; Behme D; Stadelmann C; Rohde V; Mielke D
Neurosurg Focus; 2021 Jan; 50(1):E3. PubMed ID: 33386004
[TBL] [Abstract][Full Text] [Related]
25. Intraoperative fluorescein staining for benign brain tumors.
Minkin K; Naydenov E; Gabrovski K; Dimova P; Penkov M; Tanova R; Nachev S; Romanski K
Clin Neurol Neurosurg; 2016 Oct; 149():22-6. PubMed ID: 27450764
[TBL] [Abstract][Full Text] [Related]
26. Dual-labeling with 5-aminolevulinic acid and fluorescein for fluorescence-guided resection of high-grade gliomas: technical note.
Suero Molina E; Wölfer J; Ewelt C; Ehrhardt A; Brokinkel B; Stummer W
J Neurosurg; 2018 Feb; 128(2):399-405. PubMed ID: 28338432
[TBL] [Abstract][Full Text] [Related]
27. Pathological analysis of the surgical margins of resected glioblastomas excised using photodynamic visualization with both 5-aminolevulinic acid and fluorescein sodium.
Yano H; Nakayama N; Ohe N; Miwa K; Shinoda J; Iwama T
J Neurooncol; 2017 Jun; 133(2):389-397. PubMed ID: 28432590
[TBL] [Abstract][Full Text] [Related]
28. Surgery for Glioblastoma: Impact of the Combined Use of 5-Aminolevulinic Acid and Intraoperative MRI on Extent of Resection and Survival.
Coburger J; Hagel V; Wirtz CR; König R
PLoS One; 2015; 10(6):e0131872. PubMed ID: 26115409
[TBL] [Abstract][Full Text] [Related]
29. What have we learned in fluorescein-guided resection of brain metastases? An update after 79 consecutive cases.
Falco J; Broggi M; Rubiu E; Restelli F; Pollo B; Schiariti M; Lanteri P; Stanziano M; LA Corte E; Mazzapicchi E; Vetrano IG; Ferroli P; Acerbi F
J Neurosurg Sci; 2023 Nov; ():. PubMed ID: 37971496
[TBL] [Abstract][Full Text] [Related]
30. Combined Fluorescence Using 5-Aminolevulinic Acid and Fluorescein Sodium at Glioblastoma Border: Intraoperative Findings and Histopathologic Data About 3 Newly Diagnosed Consecutive Cases.
Della Puppa A; Munari M; Gardiman MP; Volpin F
World Neurosurg; 2019 Feb; 122():e856-e863. PubMed ID: 30391771
[TBL] [Abstract][Full Text] [Related]
31. Long-term survival after glioblastoma resection: hope despite poor prognosis factors.
Costa E; Lawson TM; Lelotte J; Fomekong E; Vaz RG; Renard L; Whenham N; Raftopoulos C
J Neurosurg Sci; 2019 Jun; 63(3):251-257. PubMed ID: 29363298
[TBL] [Abstract][Full Text] [Related]
32. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
Li YM; Suki D; Hess K; Sawaya R
J Neurosurg; 2016 Apr; 124(4):977-88. PubMed ID: 26495941
[TBL] [Abstract][Full Text] [Related]
33. Enhancing tumor apparent diffusion coefficient histogram skewness stratifies the postoperative survival in recurrent glioblastoma multiforme patients undergoing salvage surgery.
Zolal A; Juratli TA; Linn J; Podlesek D; Sitoci Ficici KH; Kitzler HH; Schackert G; Sobottka SB; Rieger B; Krex D
J Neurooncol; 2016 May; 127(3):551-7. PubMed ID: 26830088
[TBL] [Abstract][Full Text] [Related]
34. Association of 5-aminolevulinic acid fluorescence guided resection with photodynamic therapy in recurrent glioblastoma: a matched cohort study.
da Silva EB; Vasquez MWM; de Almeida Teixeira BC; Neto MC; Sprenger F; Filho JLN; Almeida-Lopes L; Ramina R
Acta Neurochir (Wien); 2024 May; 166(1):212. PubMed ID: 38739282
[TBL] [Abstract][Full Text] [Related]
35. Fluorescence-guidance in non-Gadolinium enhancing, but FET-PET positive gliomas.
Schebesch KM; Brawanski A; Doenitz C; Rosengarth K; Proescholdt M; Riemenschneider MJ; Grosse J; Hellwig D; Höhne J
Clin Neurol Neurosurg; 2018 Sep; 172():177-182. PubMed ID: 30032095
[TBL] [Abstract][Full Text] [Related]
36. Ultrasound-based real-time neuronavigated fluorescence-guided surgery for high-grade gliomas: technical note and preliminary experience.
Villa A; Costantino G; Meli F; Odierna Contino A; Imperato A; Francaviglia N
Acta Neurochir (Wien); 2019 Dec; 161(12):2595-2605. PubMed ID: 31656986
[TBL] [Abstract][Full Text] [Related]
37. The use of the sodium fluorescein and YELLOW 560 nm filter for the resection of pediatric posterior fossa lesions.
Ott C; Proescholdt M; Friedrich M; Hoehne J; Rosengarth K; Schmidt NO; Schebesch KM
Childs Nerv Syst; 2023 Jun; 39(6):1495-1500. PubMed ID: 36527464
[TBL] [Abstract][Full Text] [Related]
38. Impact of extent of resection and recurrent surgery on clinical outcome and overall survival in a consecutive series of 170 patients for glioblastoma in intraoperative high field magnetic resonance imaging.
Coburger J; Wirtz CR; König RW
J Neurosurg Sci; 2017 Jun; 61(3):233-244. PubMed ID: 26149222
[TBL] [Abstract][Full Text] [Related]
39. Semi-Automated Volumetric and Morphological Assessment of Glioblastoma Resection with Fluorescence-Guided Surgery.
Cordova JS; Gurbani SS; Holder CA; Olson JJ; Schreibmann E; Shi R; Guo Y; Shu HK; Shim H; Hadjipanayis CG
Mol Imaging Biol; 2016 Jun; 18(3):454-62. PubMed ID: 26463215
[TBL] [Abstract][Full Text] [Related]
40. Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience.
Pessina F; Navarria P; Cozzi L; Ascolese AM; Simonelli M; Santoro A; Clerici E; Rossi M; Scorsetti M; Bello L
J Neurooncol; 2017 Oct; 135(1):129-139. PubMed ID: 28689368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
